This association with chemotherapy sensitivity via AQP1 occurred not only in breast cancer but also in human bladder cancer cells, where AQP1 inhibition enhanced mitomycin C sensitivity, and also in colorectal and ovarian cancers (130–132). Here, AQP1 is linked to breast carcinoma.